JPS6158196B2 - - Google Patents
Info
- Publication number
- JPS6158196B2 JPS6158196B2 JP59047931A JP4793184A JPS6158196B2 JP S6158196 B2 JPS6158196 B2 JP S6158196B2 JP 59047931 A JP59047931 A JP 59047931A JP 4793184 A JP4793184 A JP 4793184A JP S6158196 B2 JPS6158196 B2 JP S6158196B2
- Authority
- JP
- Japan
- Prior art keywords
- collagen
- layer
- heparin
- fibronectin
- antithrombotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000463 material Substances 0.000 claims description 43
- 102000008186 Collagen Human genes 0.000 claims description 34
- 108010035532 Collagen Proteins 0.000 claims description 34
- 229920001436 collagen Polymers 0.000 claims description 34
- 230000002785 anti-thrombosis Effects 0.000 claims description 29
- 229920000669 heparin Polymers 0.000 claims description 21
- 229960002897 heparin Drugs 0.000 claims description 21
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 15
- 239000003146 anticoagulant agent Substances 0.000 claims description 14
- 102000016359 Fibronectins Human genes 0.000 claims description 13
- 108010067306 Fibronectins Proteins 0.000 claims description 13
- 238000000034 method Methods 0.000 description 15
- 239000002861 polymer material Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 239000002473 artificial blood Substances 0.000 description 10
- 210000004204 blood vessel Anatomy 0.000 description 10
- 208000028659 discharge Diseases 0.000 description 9
- -1 for example Substances 0.000 description 8
- 239000002131 composite material Substances 0.000 description 7
- 239000002504 physiological saline solution Substances 0.000 description 7
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 6
- 208000007536 Thrombosis Diseases 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229920005601 base polymer Polymers 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 238000005086 pumping Methods 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920003225 polyurethane elastomer Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59047931A JPS60190966A (ja) | 1984-03-13 | 1984-03-13 | 抗血栓性材料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59047931A JPS60190966A (ja) | 1984-03-13 | 1984-03-13 | 抗血栓性材料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60190966A JPS60190966A (ja) | 1985-09-28 |
| JPS6158196B2 true JPS6158196B2 (fr) | 1986-12-10 |
Family
ID=12789112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59047931A Granted JPS60190966A (ja) | 1984-03-13 | 1984-03-13 | 抗血栓性材料 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60190966A (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5037377A (en) * | 1984-11-28 | 1991-08-06 | Medtronic, Inc. | Means for improving biocompatibility of implants, particularly of vascular grafts |
| US4743252A (en) * | 1986-01-13 | 1988-05-10 | Corvita Corporation | Composite grafts |
| DE3778195D1 (de) * | 1986-04-07 | 1992-05-21 | Agency Ind Science Techn | Antithrombogenisches material. |
| JP2692722B2 (ja) * | 1992-10-06 | 1997-12-17 | 株式会社東洋電機工業所 | 掘削カッター装置付の水中ポンプ |
| WO1995010989A1 (fr) * | 1993-10-19 | 1995-04-27 | Scimed Life Systems, Inc. | Pompe intravasculaire a effet extenseur |
| WO1998024385A1 (fr) * | 1996-12-06 | 1998-06-11 | Tapic International Co., Ltd. | Vaisseau sanguin artificiel |
-
1984
- 1984-03-13 JP JP59047931A patent/JPS60190966A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60190966A (ja) | 1985-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5028597A (en) | Antithrombogenic materials | |
| US5578073A (en) | Thromboresistant surface treatment for biomaterials | |
| JP4383851B2 (ja) | 多糖類生体材料及びその使用 | |
| US5098977A (en) | Methods and compositions for providing articles having improved biocompatability characteristics | |
| JP2561309B2 (ja) | 医療用材料およびその製造方法 | |
| JP2001500408A (ja) | 共有結合ヘパリンを含む表面コーティングを介した有意な開通性強化を有するｅＰＴＦＥ小直径血管移植片 | |
| DE3639561C2 (fr) | ||
| JPH0751353A (ja) | 固体表面に生体分子を結合させるスペーサーの製造方法及び固体表面に生体分子を共有結合させるための基質 | |
| JPH03254752A (ja) | 人工血管及びその製造方法 | |
| WO1992009312A1 (fr) | Materiau pour implants | |
| EP0366564A2 (fr) | Matériau médical antithrombotique, organe interne artificiel et méthode de production d'un matériau médical antithrombotique | |
| US5098960A (en) | Methods and compositions for providing articles having improved biocompatibility characteristics | |
| EP0781089B1 (fr) | Traitement de surface thromboresistant pour biomateriaux | |
| Sipehia et al. | Enhanced albumin binding to polypropylene beads via anhydrous ammonia gaseous plasma | |
| WO1996008149A9 (fr) | Traitement de surface thromboresistant pour biomateriaux | |
| JPS6158196B2 (fr) | ||
| JPS6344383B2 (fr) | ||
| US5017670A (en) | Methods and compositions for providing articles having improved biocompatibility characteristics | |
| JPH07184989A (ja) | 血液適合性医療用高分子材料および医療材料 | |
| CA1299937C (fr) | Materiel antithrombogene | |
| JPS61263448A (ja) | 血管補綴物 | |
| Wilson | Hemocompatible polymers: preparation and properties | |
| JP3687995B2 (ja) | 人工血管及びその製造方法 | |
| EP0282091A2 (fr) | Article médical libérant de l'héparine de façon contrôlée | |
| CN114306758A (zh) | 一种长效抗凝血涂层、制备方法及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |